RecallGuide.ca
    Health productsUpdated Jan 3, 2026ZantacOfficial source

    Sanofi Consumer Health Zantac recall in Canada: impurity risk

    Share:

    In plain language

    This recall involves Sanofi Consumer Health Zantac 75 mg and 150 mg tablets sold in Canada. It's being recalled because affected lots may contain an impurity called N-nitrosodimethylamine (NDMA). Stop using the product and follow the return steps in the official notice.

    What to do

    • Stop using the product immediately.
    • Check the product name and strength.
    • Contact your healthcare provider for advice.
    • Follow Health Canada's guidance regarding the recall.

    Get alerts for recalls like this

    Get email alerts when new recalls affect products in this category.

    Categories (optional)

    No spam. Unsubscribe anytime. We only email when there's a relevant recall.

    Affected products

    • Zantac 75 mg Tablet

      Lot: All lots

    • Zantac 150 mg Tablet

      Lot: All lots

    Why this matters

    Impurity risk

    Do I have this product?

    This recall only applies to specific products. Follow the steps below to check.

    1. 1

      Check the product name

      Make sure your product name matches one of the affected products listed above.

    2. 2

      Check the lot number

      Lot numbers identify specific production batches.

      Affected lots: All lots

    If your product matches one or more of the details above, it may be affected by this recall.

    If your product does not match these details, it is not affected by this recall.

    When in doubt, always check the official notice.

    Want alerts if similar products are recalled in Canada?

    Frequently Asked Questions

    Why was this product recalled?

    Impurity risk

    What should consumers do?

    Stop using the product immediately. Check the product name and strength. Contact your healthcare provider for advice. Follow Health Canada's guidance regarding the recall.

    Where was the product sold?

    This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.

    Is there a health risk?

    Yes, there may be a health risk. Impurity risk

    When was this product recalled?

    This product was recalled on October 18, 2019.

    Is the Zantac brand affected by this recall?

    Yes, Zantac products are affected by this recall. This recall involves Sanofi Consumer Health Zantac 75 mg and 150 mg tablets sold in Canada. It's being recalled because affected lots may contain an impurity called N-nitrosodimethylamine (NDMA). Stop using the product and follow the return steps in the official notice.